DactinomycinDoxorubicinGestational Trophoblastic DiseaseWilms TumorVincristineLeukocyte DisordersRhabdomyosarcomaTrophoblastic NeoplasmsPulse Therapy, DrugAntibiotics, AntineoplasticIfosfamideAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideEtoposideSarcoma, EwingCombined Modality TherapyKidney NeoplasmsNeoplasms, Germ Cell and EmbryonalBleomycinMethotrexateDrug Administration ScheduleBone NeoplasmsTreatment OutcomeDisease-Free SurvivalRazoxaneNeoplasm Recurrence, LocalNeoplasm StagingAntineoplastic AgentsSurvival RateDrug Resistance, NeoplasmDrug CarriersLiposomesP-GlycoproteinDrug Resistance, MultiplePrednisoneBreast NeoplasmsCell Line, TumorPolyethylene GlycolsPaclitaxelVinblastineCisplatinDaunorubicinDose-Response Relationship, DrugLeukemia P388CardiotoxinsHydroxyethylrutosideDrug SynergismApoptosisSarcomaTumor Cells, CulturedAnthracyclinesDrug Delivery SystemsDrug ResistanceCell SurvivalDrug Screening Assays, AntitumorMitoxantroneSurvival AnalysisInfusions, IntravenousCardiomyopathiesHeart DiseasesVerapamilHeartOsteosarcomaFluorouracilAntineoplastic Agents, PhytogenicTaxoidsDNA Topoisomerases, Type IIMice, NudeChemotherapy, AdjuvantNaphthacenesProcarbazineProdrugsNanocapsulesEpirubicinAclarubicinOvarian NeoplasmsXenograft Model Antitumor AssaysSoft Tissue NeoplasmsNeoplasm Transplantation